{"count": 10, "results": [{"_id": "32907360", "pmid": 32907360, "title": "Combination of Scutellaria baicalensis and Metformin Ameliorates Diet-Induced Metabolic Dysregulation in Mice via the Gut-Liver-Brain Axis.", "journal": "Am J Chin Med", "authors": ["Ansari A", "Bose S", "Lim SK", "Wang JH", "Choi YH", "Kim H"], "date": "2020-01-01T00:00:00Z", "doi": "10.1142/S0192415X2050069X", "meta_date_publication": "2020", "meta_volume": "48", "meta_issue": "6", "meta_pages": "1409-1433", "score": 50263.402, "text_hl": "Combination of Scutellaria baicalensis and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Ameliorates Diet-Induced @<m>DISEASE_Chronobiology_Disorders</m> @DISEASE_MESH:D021081 @@@Metabolic Dysregulation@@@ in @SPECIES_10090 @@@Mice@@@ via the Gut-Liver-Brain Axis.", "citations": {"NLM": "Ansari A, Bose S, Lim SK, Wang JH, Choi YH, Kim H. Combination of Scutellaria baicalensis and Metformin Ameliorates Diet-Induced Metabolic Dysregulation in Mice via the Gut-Liver-Brain Axis. Am J Chin Med. 2020;48(6):1409-1433. PMID: 32907360", "BibTeX": "@article{32907360, title={Combination of Scutellaria baicalensis and Metformin Ameliorates Diet-Induced Metabolic Dysregulation in Mice via the Gut-Liver-Brain Axis.}, author={Ansari A and Bose S and Lim SK and Wang JH and Choi YH and Kim H}, journal={Am J Chin Med}, volume={48}, number={6}, pages={1409-1433}}"}}, {"_id": "33107770", "pmid": 33107770, "title": "Circadian rhythms in diabetic retinopathy: an overview of pathogenesis and investigational drugs.", "journal": "Expert Opin Investig Drugs", "authors": ["Bhatwadekar AD", "Rameswara V"], "date": "2020-12-01T00:00:00Z", "doi": "10.1080/13543784.2020.1842872", "meta_date_publication": "2020 Dec", "meta_volume": "29", "meta_issue": "12", "meta_pages": "1431-1442", "score": 50248.76, "text_hl": "The latter part of the paper sheds light on those investigational drugs (such as @CHEMICAL_Melatonin @CHEMICAL_MESH:D008550 @@@melatonin@@@, @CHEMICAL_tasimelteon @CHEMICAL_MESH:C478745 @@@tasimelteon@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@) which exhibit potential in the treatment of @DISEASE_Diabetic_Retinopathy @DISEASE_MESH:D003930 @@@DR@@@ by the targeting of circadian @<m>DISEASE_Chronobiology_Disorders</m> @DISEASE_MESH:D021081 @@@rhythm dysfunction@@@. ", "citations": {"NLM": "Bhatwadekar AD, Rameswara V. Circadian rhythms in diabetic retinopathy: an overview of pathogenesis and investigational drugs. Expert Opin Investig Drugs. 2020 Dec;29(12):1431-1442. PMID: 33107770", "BibTeX": "@article{33107770, title={Circadian rhythms in diabetic retinopathy: an overview of pathogenesis and investigational drugs.}, author={Bhatwadekar AD and Rameswara V}, journal={Expert Opin Investig Drugs}, volume={29}, number={12}, pages={1431-1442}}"}}, {"_id": "34383179", "pmid": 34383179, "title": "A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density.", "journal": "Breast Cancer Res Treat", "authors": ["Tapia E", "Villa-Guillen DE", "Chalasani P", "Centuori S", "Roe DJ", "Guillen-Rodriguez J", "Huang C", "Galons JP", "Thomson CA", "Altbach M", "Trujillo J", "Pinto L", "Martinez JA", "Algotar AM", "Chow HS"], "date": "2021-11-01T00:00:00Z", "doi": "10.1007/s10549-021-06355-9", "meta_date_publication": "2021 Nov", "meta_volume": "190", "meta_issue": "1", "meta_pages": "69-78", "score": 50244.67, "text_hl": "CONCLUSION: We conclude that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ intervention resulted in favorable changes in anthropometric measures of @DISEASE_Neoplasms_Adipose_Tissue @DISEASE_MESH:D018205 @@@adiposity@@@ and a borderline decrease in non-dense breast volume in @SPECIES_9606 @@@women@@@ with @<m>DISEASE_Chronobiology_Disorders</m> @DISEASE_MESH:D021081 @@@metabolic dysregulation@@@. ", "citations": {"NLM": "Tapia E, Villa-Guillen DE, Chalasani P, Centuori S, Roe DJ, Guillen-Rodriguez J, Huang C, Galons JP, Thomson CA, Altbach M, Trujillo J, Pinto L, Martinez JA, Algotar AM, Chow HS. A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density. Breast Cancer Res Treat. 2021 Nov;190(1):69-78. PMID: 34383179", "BibTeX": "@article{34383179, title={A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density.}, author={Tapia E and Villa-Guillen DE and Chalasani P and Centuori S and Roe DJ and Guillen-Rodriguez J and Huang C and Galons JP and Thomson CA and Altbach M and Trujillo J and Pinto L and Martinez JA and Algotar AM and Chow HS}, journal={Breast Cancer Res Treat}, volume={190}, number={1}, pages={69-78}}"}}, {"_id": "40784271", "pmid": 40784271, "title": "Metformin inhibits NF-kappaB p65/RelA-NLRP3 inflammasome-IL-1beta axis, attenuates lipid droplet accumulation, and reprograms CD14/CD16 expression in monocytes exposed to colorectal tumor-conditioned medium.", "journal": "Int Immunopharmacol", "authors": ["Djebri NC", "Zoudji S", "Messaoud A", "Messali R", "Loudjedi S", "Aribi M"], "date": "2025-08-09T00:00:00Z", "doi": "10.1016/j.intimp.2025.115299", "meta_date_publication": "2025 Aug 9", "meta_volume": "164", "meta_issue": "", "meta_pages": "115299", "score": 50240.3, "text_hl": "Key aspects of this environment can be mimicked by @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@-conditioned medium (TCM). @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has emerged as a promising candidate to counteract TCM-induced immune and @<m>DISEASE_Chronobiology_Disorders</m> @DISEASE_MESH:D021081 @@@inflammatory dysregulation@@@. ", "citations": {"NLM": "Djebri NC, Zoudji S, Messaoud A, Messali R, Loudjedi S, Aribi M. Metformin inhibits NF-kappaB p65/RelA-NLRP3 inflammasome-IL-1beta axis, attenuates lipid droplet accumulation, and reprograms CD14/CD16 expression in monocytes exposed to colorectal tumor-conditioned medium. Int Immunopharmacol. 2025 Aug 9;164():115299. PMID: 40784271", "BibTeX": "@article{40784271, title={Metformin inhibits NF-kappaB p65/RelA-NLRP3 inflammasome-IL-1beta axis, attenuates lipid droplet accumulation, and reprograms CD14/CD16 expression in monocytes exposed to colorectal tumor-conditioned medium.}, author={Djebri NC and Zoudji S and Messaoud A and Messali R and Loudjedi S and Aribi M}, journal={Int Immunopharmacol}, volume={164}, pages={115299}}"}}, {"_id": "34659571", "pmid": 34659571, "pmcid": "PMC8517991", "title": "Multifactorial causation of early onset colorectal cancer", "journal": "J Cancer", "authors": ["Lazarova D", "Bordonaro M"], "date": "2021-09-24T00:00:00Z", "doi": "10.7150/jca.63676", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "22", "meta_pages": "6825-6834", "score": 50238.17, "text_hl": "First, older individuals with @<m>DISEASE_Chronobiology_Disorders</m> @DISEASE_MESH:D021081 @@@metabolic dysregulation@@@ are more frequently on maintenance medications, such as @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@, beta-blockers, @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@-lowering drugs, ACE inhibitors, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, etc., compared to younger individuals. ", "citations": {"NLM": "Lazarova D, Bordonaro M. Multifactorial causation of early onset colorectal cancer J Cancer. 2021;12(22):6825-6834. PMID: 34659571", "BibTeX": "@article{34659571, title={Multifactorial causation of early onset colorectal cancer}, author={Lazarova D and Bordonaro M}, journal={J Cancer}, volume={12}, number={22}, pages={6825-6834}}"}}, {"_id": "29739273", "pmid": 29739273, "title": "Angiogenic Dysregulation in Pregnancy-Related Hypertension-A Role for Metformin.", "journal": "Reprod Sci", "authors": ["Soobryan N", "Murugesan S", "Pandiyan A", "Moodley J", "Mackraj I"], "date": "2018-11-01T00:00:00Z", "doi": "10.1177/1933719118773484", "meta_date_publication": "2018 Nov", "meta_volume": "25", "meta_issue": "11", "meta_pages": "1531-1539", "score": 50075.445, "text_hl": "@<m>DISEASE_Chronobiology_Disorders</m> @DISEASE_MESH:D021081 @@@Angiogenic Dysregulation@@@ in @DISEASE_Hypertension_Pregnancy_Induced @DISEASE_MESH:D046110 @@@Pregnancy-Related Hypertension@@@-A Role for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@.", "citations": {"NLM": "Soobryan N, Murugesan S, Pandiyan A, Moodley J, Mackraj I. Angiogenic Dysregulation in Pregnancy-Related Hypertension-A Role for Metformin. Reprod Sci. 2018 Nov;25(11):1531-1539. PMID: 29739273", "BibTeX": "@article{29739273, title={Angiogenic Dysregulation in Pregnancy-Related Hypertension-A Role for Metformin.}, author={Soobryan N and Murugesan S and Pandiyan A and Moodley J and Mackraj I}, journal={Reprod Sci}, volume={25}, number={11}, pages={1531-1539}}"}}, {"_id": "18082302", "pmid": 18082302, "title": "Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine.", "journal": "Prog Neuropsychopharmacol Biol Psychiatry", "authors": ["Chen CH", "Chiu CC", "Huang MC", "Wu TH", "Liu HC", "Lu ML"], "date": "2008-05-15T00:00:00Z", "doi": "10.1016/j.pnpbp.2007.11.013", "meta_date_publication": "2008 May 15", "meta_volume": "32", "meta_issue": "4", "meta_pages": "925-31", "score": 50068.973, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ for @<m>DISEASE_Chronobiology_Disorders</m> @DISEASE_MESH:D021081 @@@metabolic dysregulation@@@ in @DISEASE_Schizophrenia @DISEASE_MESH:D012559 @@@schizophrenic@@@ @SPECIES_9606 @@@patients@@@ treated with @CHEMICAL_Olanzapine @CHEMICAL_MESH:D000077152 @@@olanzapine@@@.", "citations": {"NLM": "Chen CH, Chiu CC, Huang MC, Wu TH, Liu HC, Lu ML. Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):925-31. PMID: 18082302", "BibTeX": "@article{18082302, title={Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine.}, author={Chen CH and Chiu CC and Huang MC and Wu TH and Liu HC and Lu ML}, journal={Prog Neuropsychopharmacol Biol Psychiatry}, volume={32}, number={4}, pages={925-31}}"}}, {"_id": "26506839", "pmid": 26506839, "title": "Metformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells.", "journal": "Genes Nutr", "authors": ["Montales MT", "Simmen RC", "Ferreira ES", "Neves VA", "Simmen FA"], "date": "2015-11-01T00:00:00Z", "doi": "10.1007/s12263-015-0499-6", "meta_date_publication": "2015 Nov", "meta_volume": "10", "meta_issue": "6", "meta_pages": "49", "score": 50049.273, "text_hl": "In cells under a @DISEASE_Congenital_Hyperinsulinism @DISEASE_MESH:D044903 @@@hyperinsulinemic@@@ state mimicking @<m>DISEASE_Chronobiology_Disorders</m> @DISEASE_MESH:D021081 @@@metabolic dysregulation@@@ and without and with added @GENE_PTEN @GENE_5728 @@@PTEN@@@-specific inhibitor @CHEMICAL_SF1670 @CHEMICAL_MESH:C000619508 @@@SF1670@@@, colonosphere formation and frequency of the @GENE_PROM1 @GENE_8842 @@@CD133@@@(+)@GENE_CD44 @GENE_960 @@@CD44@@@(+) subpopulation were decreased by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@, Lun and @CHEMICAL_Genistein @CHEMICAL_MESH:D019833 @@@Gen@@@, alone and when combined. ", "citations": {"NLM": "Montales MT, Simmen RC, Ferreira ES, Neves VA, Simmen FA. Metformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells. Genes Nutr. 2015 Nov;10(6):49. PMID: 26506839", "BibTeX": "@article{26506839, title={Metformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells.}, author={Montales MT and Simmen RC and Ferreira ES and Neves VA and Simmen FA}, journal={Genes Nutr}, volume={10}, number={6}, pages={49}}"}}, {"_id": "28559290", "pmid": 28559290, "title": "A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses.", "journal": "J Mol Endocrinol", "authors": ["Qi T", "Chen Y", "Li H", "Pei Y", "Woo SL", "Guo X", "Zhao J", "Qian X", "Awika J", "Huo Y", "Wu C"], "date": "2017-07-01T00:00:00Z", "doi": "10.1530/JME-17-0066", "meta_date_publication": "2017 Jul", "meta_volume": "59", "meta_issue": "1", "meta_pages": "49-59", "score": 50048.695, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ improves @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@-associated @<m>DISEASE_Chronobiology_Disorders</m> @DISEASE_MESH:D021081 @@@metabolic dysregulation@@@, but has controversial effects on adipose @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@tissue inflammation@@@. ", "citations": {"NLM": "Qi T, Chen Y, Li H, Pei Y, Woo SL, Guo X, Zhao J, Qian X, Awika J, Huo Y, Wu C. A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses. J Mol Endocrinol. 2017 Jul;59(1):49-59. PMID: 28559290", "BibTeX": "@article{28559290, title={A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses.}, author={Qi T and Chen Y and Li H and Pei Y and Woo SL and Guo X and Zhao J and Qian X and Awika J and Huo Y and Wu C}, journal={J Mol Endocrinol}, volume={59}, number={1}, pages={49-59}}"}}, {"_id": "22640703", "pmid": 22640703, "title": "Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats.", "journal": "J Psychiatry Neurosci", "authors": ["Boyda HN", "Procyshyn RM", "Tse L", "Hawkes E", "Jin CH", "Pang CC", "Honer WG", "Barr AM"], "date": "2012-11-01T00:00:00Z", "doi": "10.1503/jpn.110140", "meta_date_publication": "2012 Nov", "meta_volume": "37", "meta_issue": "6", "meta_pages": "407-15", "score": 50039.348, "text_hl": "METHODS: We compared the effects of 3 distinct classes of antidiabetic drugs, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (100 and 500 mg/kg, oral), @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@ (6 and 30 mg/kg, oral) and @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glyburide@@@ (2 and 10 mg/kg, oral), on olanzapineinduced @<m>DISEASE_Chronobiology_Disorders</m> @DISEASE_MESH:D021081 @@@metabolic dysregulation@@@. ", "citations": {"NLM": "Boyda HN, Procyshyn RM, Tse L, Hawkes E, Jin CH, Pang CC, Honer WG, Barr AM. Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats. J Psychiatry Neurosci. 2012 Nov;37(6):407-15. PMID: 22640703", "BibTeX": "@article{22640703, title={Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats.}, author={Boyda HN and Procyshyn RM and Tse L and Hawkes E and Jin CH and Pang CC and Honer WG and Barr AM}, journal={J Psychiatry Neurosci}, volume={37}, number={6}, pages={407-15}}"}}]}